Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

NCT02836873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Bexagliflozin
DRUG: Placebo

Sponsor

Theracos